Ultrasound-guided prostate brachytherapy system receives FDA clearance

11/22/2013 | AuntMinnie.com (free registration)

CIVCO Medical Solutions has been cleared by the FDA to market its EX3 Stepper system for use in the diagnosis and treatment of prostate cancer. The company said the ultrasound-guided device, designed for both high-dose-rate and low-dose-rate brachytherapy, also received CE mark approval.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY